# NextCure, Inc.: Form 8-K, filed Mar 5, 2026

- Company: [NextCure, Inc.](/companies/nxtc.md) (CIK 1661059)
- Form: 8-K
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 5, 2026, 16:15 ET
- Period: 2026-03-05
- Accession: 0001104659-26-024121
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1661059/000110465926024121/nxtc-20260305x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1661059/000110465926024121/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1661059/000110465926024121/nxtc-20260305x8k.htm

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-024121. Last ingested by Listed: Nov 2, 2026, 06:06 ET. No prices; not investment advice.